Matches in Wikidata for { <http://www.wikidata.org/entity/Q93047416> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q93047416 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q93047416 description "scientific article published on 15 July 2019" @default.
- Q93047416 description "wetenschappelijk artikel" @default.
- Q93047416 description "наукова стаття, опублікована 15 липня 2019" @default.
- Q93047416 name "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 name "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 type Item @default.
- Q93047416 label "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 label "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 prefLabel "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 prefLabel "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 P1433 Q93047416-37BF4532-11DE-4336-B432-B490346371CE @default.
- Q93047416 P1476 Q93047416-DFF69AC5-361C-47FC-916C-DA9814B1DAC0 @default.
- Q93047416 P2093 Q93047416-54F8181C-16F7-4A83-B2AC-96FDA8AD4CBC @default.
- Q93047416 P2093 Q93047416-744D4B25-A74F-48BC-8B6A-E74DB6F2D87A @default.
- Q93047416 P2093 Q93047416-94662887-8D7A-48B9-BB38-CE521032E4C4 @default.
- Q93047416 P2093 Q93047416-9B625E87-AA75-4EBC-AF87-2BBA1183DC3C @default.
- Q93047416 P2093 Q93047416-CDFB32F9-48C6-47EA-8921-4FDF285BC586 @default.
- Q93047416 P2093 Q93047416-CFD34011-D4BA-47EF-AF5A-136B7002070B @default.
- Q93047416 P2093 Q93047416-D65AD920-FCE6-4694-8B4E-FC484CA45445 @default.
- Q93047416 P2093 Q93047416-FE2C1085-3729-4D10-99C9-455FF0EE1FEF @default.
- Q93047416 P304 Q93047416-C234F38E-C397-4276-9E5D-E656A5C9CEEA @default.
- Q93047416 P31 Q93047416-275C0348-9765-4411-93D1-F16A5B16A4C3 @default.
- Q93047416 P356 Q93047416-DCE4579C-6F4A-4A47-AB2C-8A6C76FCE8A2 @default.
- Q93047416 P433 Q93047416-50E65BCA-FA8A-4491-A8D4-2D2AFC8EC157 @default.
- Q93047416 P478 Q93047416-A81018EF-E5A1-44CC-97BB-F3EB84B8E1F1 @default.
- Q93047416 P50 Q93047416-1F112D53-1CE1-48F8-8FE2-87D91606FCD5 @default.
- Q93047416 P50 Q93047416-B76D27C5-1A64-4568-A2B5-856A2ED549D4 @default.
- Q93047416 P577 Q93047416-5EBEB623-6A84-493C-B098-9D8478899CC4 @default.
- Q93047416 P698 Q93047416-DC3040FF-BE39-4430-8F9F-19B27C167B11 @default.
- Q93047416 P356 ACS.MOLPHARMACEUT.9B00418 @default.
- Q93047416 P698 31242389 @default.
- Q93047416 P1433 Q3011140 @default.
- Q93047416 P1476 "Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins" @default.
- Q93047416 P2093 "Alyssa Birt" @default.
- Q93047416 P2093 "Christine Ambrose" @default.
- Q93047416 P2093 "Fay J Dufort" @default.
- Q93047416 P2093 "Ian A Schrack" @default.
- Q93047416 P2093 "Lan Wu" @default.
- Q93047416 P2093 "Lihe Su" @default.
- Q93047416 P2093 "Paul D Rennert" @default.
- Q93047416 P2093 "Roy R Lobb" @default.
- Q93047416 P304 "3544-3558" @default.
- Q93047416 P31 Q13442814 @default.
- Q93047416 P356 "10.1021/ACS.MOLPHARMACEUT.9B00418" @default.
- Q93047416 P433 "8" @default.
- Q93047416 P478 "16" @default.
- Q93047416 P50 Q42318179 @default.
- Q93047416 P50 Q56223869 @default.
- Q93047416 P577 "2019-07-15T00:00:00Z" @default.
- Q93047416 P698 "31242389" @default.